Clinical Trials Browser

Interventional × Diphtheria Toxoid × 90 days × Clear all

NCT05237947 2026-04-13

PRISMA

Phase 4 Active not recruiting

Human Papillomavirus-Related Cervical Carcinoma

NCT02518555 2026-04-06

Ibrutinib as an Immune Modulating Agent for Patients With Asymptomatic, High-risk CLL/SLL Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Phase 2 Completed

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell